Abstract
Background
Soluble adhesion molecules are elevated in a number of inflammatory conditions.
Aims
To investigate the correlation of soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin with the activity of inflammatory bowel disease (IBD).
Methods
sICAM-1 and sE-selectin were measured by an enzyme-linked immunosorbent assay (ELISA) in 53 patients with ulcerative colitis (UC) and 38 patients with Crohn’s disease (CD).
Results
Patients with active UC and CD had significantly higher sICAM-1 than patients with inactive disease and controls. Paients with pancolitis had significantly higher levels than patients with distal colitis. There was a significant difference in sE-selectin levels between paients with acive CD and control sICAM-1. sE-seiectin did not correlate with the Harvey Bradshaw index (HBI). C-reactive protein (CRP) and microalbuminuria were better markers than sICAM-1 or sE-selectin which correlated with serum tumour necrosis factor (TNF)-α.
Conclusion
sICAM-1 and sE-selecin are elevated in the serum of paients with IBD but CRP and microalbuminuria reflect clinical disease activity more accurately. This study does not support the routine use of soluble adhesion molecules as disease activity markers in IBD.
Similar content being viewed by others
References
Springer TA. Adhesion receptors of the immune system.Nature 1990; 346; 425–34.
Van de Stolpe A, Van der Stag PT. Intercellular adhesion molecule-1.J Mol Med 1996; 74 (1): 13–33.
Martin SD, Springer TA. Purified intercellular adhesion molecule 1 is a ligand for lymphocyte fonction associated antigen 1.Cell 1987; 51: 813.
Diamond MS, Staunton DE, DeFourgerolles AR et al. ICAM-1 (CD54): a counter receptor for Mac-1(CD11b/CD18).J Cell Biol 111: 3129.
Bird MI, Foster MR, Priest R, Malhotra R. Selectins; physiological and pathophysiological roles.Biochem Soc Trans 1997; 25 (4); 1199–206.
Yoshida M, Gimbrone MAJ. Novel roles for E-selectin in endothelial-leucocyte adhesion.Ann N Y Acad Sci 1997; 811: 493–97.
Collins T, Read MA, Neish AS et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-kB and cytokine-indudble enhancers.FASEB J 1995; 9 (10): 899–909.
Malizia G, Calabrese A, Cottone E et al. Expression of leucocyte adhesion molecules by mononuclear phagocytes in inflammatory bowel disease.Gastroenterology 1991; 100: 150–9.
Koizumi M, King N, Lobb R; Benjamin C, Podolsky DK. Expression of vascular adhesion molecules in inflammatory bowel disease.Gastroenterology 1992; 103: 840–7.
Ohtani H, Makamura S, Watanabe Y et al. Light and election microscopic immunolocalization of endothelial leucocyte adhesion molecule-1 in inflammatory bowel disease. Morphological evidence of active synthesis and secretion into vascular lumen.Virchows Arch A Pathol Anat Histopathol 1992; 420: 403–9.
Nielsen OH, Brynskov J, Vainer B. Increased mucosal concentrations of soluble intercellular adhesion molecule-1 (ICAM-1), sE-selectin, and interleukin-8 in active ulcerative colitis.Dig Dis Sci 1996; 41 (9): 1780–5.
Bhatti M, Chapman P, Peters M, Haskard D, Hodgson HJ. Visualising E-selectin in the detection and evaluation of inflammatory bowel disease.Gut 1998; 43 (1): 40–7.
Schurmann GM, Bishop AB, Facer P et al. Increased expression of cell adhesion molecule p-selectin in active inflammatory bowel disease.Gut 1995; 36 (3): 411–18.
Taniguchi T, Tsukada H, Nakamura H et al. Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats.J Gastroenterol Hepatol 1998; 13 (9): 945–9.
Yacyshyn BR, Bowen-Yachsyn MB, Jewell L et al. A place-bo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn’s disease.Gastroenterology 1998; 114: 1133–42.
Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders.Lancet 1991; 338: 83–4.
Patel RT, Pall AA, Adu D et al. Circulating soluble adhesion molecules in inflammatory bowel disease.Eur J Gastroenterol Hepatol 1995; 7: 1037–41.
Jones SC, Banks RE, Haidar A et al. Adhesion molecules in inflammatory bowel disease.Gut 1995; 36: 724–30.
Goke M, Hoffman JC, Evers J et al. Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease.J Gastroenterol 1997; 32: 480–6.
Banks RE, Gearing AJH, Hemingway IK et al. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies.Br J Cancer 1993; 68: 122–4.
Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NHH. Established and emerging biological activity markers of inflammatory bowel disease.Ant J Gastroenterol 2000; 95 (2): 359–67.
Wakefield AJ, Sawyer AM, Dhillon AP et al. Pathogenesis of Crohn’s disease: multifocal gastrointestinal infarction.Lancet 1989; 2: 1057–62.
Wakefield AJ, Montgomery SM, Measles virus as a risk for inflammatory bowel disease: an unusually tolerant approach.Am J Gastroenterol 2000; 95(6): 1389–92.
Mahmud N, McDonald GS, Kelleher D, Weir DG. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease.Gut 1996; 38 (1): 99–103.
Cush JJ, Rothlein R, Lindsley HB, Mainolfi EA, Lipsky PE. Increased levels of circulating intercellular adhesion molecule-1 in the sera of patients with rheumatoid arthritis.Arthritis Rheum 1993; 36: 1098–102.
Terada N, Konno A, Yamashita T et al. Serum level of soluble ICAM-1 in subjects with nasal allergy and ICAM-1 mRNA expression in nasal mucosa.Arerugi 1993; 42: 87–93.
Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leucocyte adhesion to endothelial cells and expression of endothelial-leucocyte adhesion molecule 1 and intercellular adhesion molecule 1.Proc Natl Acad Sci USA 1992; 89: 9991–5.
Liden J, Rafter I, Truss M, Gustafsson JA, Okret S. Glucocorticoid effects on NF-kappaB binding in the transcription of ICAM-1 gene.Biochem Biophys Res Commun 2000; 14 (273): 1008–14.
Greenfield SM, Hamblin AS, Shakoor ZS et al. Inhibition of leucocyte adhesion molecule upregulation by tumour necrosis factor a: a novel mechanism of action of sulphasalazine.Gut 1993; 34: 252–6.
Mazlana MZ, Hodgson HJF. Why measure C-reactive protein.Gut 1994; 35: 5–7.
Mahmud N, Stinson J, O’Connell M et al. Microalbuminuria in patients with inflammatory bowel disease.Gut 1994; 35: 1599–604.
Reimund JM, Duclos B, Sapin R et al. Systemic tumour necrosis factor in Crohn’s disease: relationship to disease activity and circulating acute phase reactants.Eur J Gastroenterol Hepatol 1992; 4: 919–23.
Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis.Gastroenterology 1998; 115 (1): 182–205.
Sands BE. Therapy of inflammatory bowel disease.Gastroenterology 2000; 118: S68-S82.
Rahman A, Anwar KN, Malik Ab. Protein kinase C-zeta mediates TNF-alpha-induced ICAM-1 gene transcription in endothelial cells.Am J Physiol Cell Physiol 2000; 279 (4): C906-C914.
Takahashi H, Soderstrom K, Nilsson E, Kiessling R, Patarroyo M. Integrins and other adhesion molecules on lymphocytes from synovial fluid and peripheral blood of rheumatoid arthritis patiente.Eur J Immunol 1992; 22: 2879.
Greenfield SM, Hamblin A, Punchard NA, Thompson RPH. Expression of adhesion molecules on circulating leucocytes in patients with inflammatory bowel disease.Clin Sci 1992; 83: 221–6.
Senju M, Hulstaert F, Lewder J, Jewel DP. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn’s disease.Gut 1991; 32: 779–83.
Bernstein CN, Sargent M, Rawsthorne P, Rector E. Peripheral blood lymphocyte beta 2 integrin and ICAM expression in inflammatory bowel disease.Dig Dis Sci 1997; 42: 2338.
Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum.J Immunol 1991; 147: 3788–93.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goggins, M.G., Goh, J., O’Connell, M.A. et al. Soluble adhesion molecules in inflammatory bowel disease. Ir J Med Sci 170, 107–111 (2001). https://doi.org/10.1007/BF03168821
Issue Date:
DOI: https://doi.org/10.1007/BF03168821